Researchers at Harvard University’s Wyss Institute for Biologically Inspired Engineering recently received $3.5 million in life science funding from the NIH. The grant is called a Transformative Research Award. The NIH’s aim in creating this grant is to fund high-risk, high-reward research. According to News Medical, the NIH funded only 10 of these projects in 2013, one of which is Harvard University’s DNA-based microscopy method of viewing cells.
Tags: 2014, Harvard University, 2013, Northeast, Massachusetts, Boston, BioResearch Product Faire Event, MA, Harvard, NIH funding, NIH grant, NIH award
Lab suppliers working to market life science solutions in Philadelphia will find a market rich with life science funding at Thomas Jefferson University. According to recent NIH and NSF funding statistics, the NIH awarded Thomas Jefferson University $49.7 million in research funding in 2012. In addition to receiving NIH research funding, Thomas Jefferson University received $318,984 in NSF life science funding for life science projects alone.
Tags: 2014, 2013, Pennsylvania, Northeast, Thomas Jefferson University, Philadelphia, BioResearch Product Faire Event, PA, NIH funding, NIH grant, NIH award, ThomJeff
Tags: 2014, Harvard University, 2013, Northeast, Boston, BioResearch Product Faire Event, MA, Harvard, NIH funding, NIH grant, NIH award
Lab suppliers interested in learning about the laboratory sales market in Georgia may be interested to know that the University of Georgia, Athens recently received $2.9 million in life science research funding from the NIH this year for researchers to study stem cell and induced pluripotent stem cells. According to the NIH RePORTER, the project leader is Dr. Michael Pierce. The project abstract provides more information about what the life science funding will be spent studying:
Tags: 2014, 2013, University of Georgia, Southern, UGA, BioResearch Product Faire Event, Athens, GA, NIH funding, NIH grant, NIH award
Researchers at Washington University in St. Louis recently received a great deal of life science research funding for leukemia research. The National Cancer Institute, part of the National Institutes of Health (NIH), gave the university two grants totaling $26 million. The money will be given to leukemia researchers and physicians at Siteman Cancer Center at the Washington University School of Medicine, according to St. Louis American Local News.
Tags: 2014, Midwest, 2013, Washington University, Missouri, WashU, Washington University in St. Louis, St. Louis Bioresearch Product Faire Event, BioResearch Product Faire Event, MO, St Louis, NIH funding, NIH grant, NIH award
Texas A&M researchers recently received $1.8 million in life science research funding from the NIH. The project receiving funding, titled “Structure-Based Discovery of Critical Vulnerabilities of Microbacteria,” will be led by James Sacchettini, PhD. According to Texas A&M University, Dr. Sacchettini is a professor of biochemistry, chemistry and biophysics. His research interests are using X-ray crystallography to better understand the relationship between proteins and ligands. The NIH RePORTER provides more insight intothe project receiving life science research funding this year:
Tags: 2014, 2013, Texas, Southwest, College Station, TAMU, BioResearch Product Faire Event, TX, Texas A&M, NIH funding, NIH grant, NIH award
The University of Alabama at Birmingham recently received a $4.6 million life science research funding grant from the NIH for the school’s Center for Clinical and Translational Science. Dr. Robert Kimberly is listed as the project leader. According to the University of Alabama, Dr. Kimberly is Senior Associate Dean for Research and Director of the University of Alabama at Birmingham Arthritis and Musculoskeletal Center (AMC). He is also a rheumatologist and immunologist whose research interests include autoimmune disease, systemic lupus erythematosus, systemic vasculitis and rheumatoid arthritis. The NIH RePORTER provides more information on the center receiving the latest $4.6 million in life science funding.
Tags: 2014, 2013, University of Alabama, Southern, BioResearch Product Faire Event, UAlab, Birmingham, AL, NIH funding, NIH grant, NIH award
Researchers at the University of Arizona recently received $1.2 million in NIH life science funding for a project titled “Selenium Colorectal Cancer Chemoprevention Agents.” The project start date is listed as August 1st, 2013. The NIH RePORTER goes into more detail about what the researchers are working to accomplish:
Tags: 2014, 2013, University of Arizona, Northwest, Arizona, AZ, UAZ, BioResearch Product Faire Event, Front Line, Tucson, NIH funding, NIH grant, NIH award
“Lombardi's mission is to prevent, treat and cure cancers, through cutting-edge research, expert and compassionate patient care, education of future cancer specialists, and service to the community,” says the Georgetown University Lombardi Comprehensive Cancer Center funding application and project abstract listed on NIH RePORTER. The Lombardi Comprehensive Cancer Center was recently awarded $1.4 million this year. “Lombardi is the only NCI-designated cancer center in the nation's capital and in the Washington metropolitan area. The District of Columbia has among the highest cancer mortality rates in the country. Thus, there is a clear need for an NCI-designated comprehensive cancer center that can bring a targeted, evidence-based strategy to cancer care and prevention to help improve the health of the community's residents.”
Tags: 2013, Georgetown University, Washington DC, Northeast, D.C., Geotwn, BioResearch Product Faire Event, NIH funding, NIH grant, NIH award
Researchers at the University of Alabama at Birmingham, led by Donald Buchsbaum, PhD, received a $2.2 million grant from the NIH this year to study pancreatic cancer. According to the University of Alabama website, Dr. Buchsbaum is quoted as saying of his research goals: "My interests are focused on the use of monoclonal antibodies that bind to the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors for cancer therapy in combination with chemotherapy agents and radiation.” Dr. Buchsbaum and his research team began receiving funding for their studies of pancreatic cancer six years ago, though funding was limited at that time. The NIH RePORTER sheds light on the project that has received $2.2 million from the NIH this year in the proposal’s abstract:
Tags: 2014, 2013, Alabama, University of Alabama, Southern, BioResearch Product Faire Event, UAlab, Birmingham, AL, NIH funding, NIH grant, NIH award, University of Alabama at Birmingham